Advertisement
Amazon
Amazon

The Scientist

» mass spectrometry and immunology

Most Recent

image: Cancer-Causing Gut Bacteria

Cancer-Causing Gut Bacteria

By | August 17, 2012

Mice with inflammatory bowel disease harbor gut bacteria that damage host DNA, predisposing mice to cancer.

1 Comment

image: Immunologist Falsified Data

Immunologist Falsified Data

By | August 6, 2012

A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.

9 Comments

image: Lymphatic Lines

Lymphatic Lines

By | August 1, 2012

Lymphatic vessels grow towards two chemokines, revealing signals that could be important in cancer metastasis.

0 Comments

image: Lipids in the Spotlight

Lipids in the Spotlight

By | August 1, 2012

A guide to studying lipids using mass spectrometry

0 Comments

image: Proteome Portraits

Proteome Portraits

By | August 1, 2012

Innovations in mass spectrometry are making quick, comprehensive, and easy proteome mapping more attainable than ever.

0 Comments

image: Skin Microbes Alter Immunity

Skin Microbes Alter Immunity

By | July 30, 2012

Like commensal gut organisms, skin microbiota appear to help the mammalian immune system mature and stay regulated.

0 Comments

image: Ubiquitin Chains in Action

Ubiquitin Chains in Action

By | July 1, 2012

Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role

0 Comments

image: You Are Where You Eat

You Are Where You Eat

By | July 1, 2012

Laser-based isotope detection systems are moving into the realm of food authentication.

1 Comment

image: The Fungus Among Us

The Fungus Among Us

By | June 11, 2012

Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.

1 Comment

image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.

0 Comments

Advertisement

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Exploring Emotional Contagion
  4. Immune Defect Detected in Knockout Mice
Advertisement
LabX
LabX
Advertisement
Biosearch Technologies
illumina Corporate
illumina Corporate